Comparison of <sup>18</sup>F-FDG PET/CT and DW-MRI in assessment of neoadjuvant radiochemotherapy response in locally advanced rectal cancer patients.

Uslu-Beşli, RABİA; Mermut, Ö; Yardimci, A; Gündoğan, C; Gürsu, R; Çermik, T

doi:10.1016/j.remn.2020.02.003

Comparison of <sup>18</sup>F-FDG PET/CT and DW-MRI in assessment of neoadjuvant radiochemotherapy response in locally advanced rectal cancer patients.

Uslu-Beşli L., Mermut Ö., Yardimci A. H., Gündoğan C., Gürsu R. U., Çermik T. F.

Revista espanola de medicina nuclear e imagen molecular, cilt.40, ss.19-29, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 40
Basım Tarihi: 2021
Doi Numarası: 10.1016/j.remn.2020.02.003
Dergi Adı: Revista espanola de medicina nuclear e imagen molecular
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, DIALNET
Sayfa Sayıları: ss.19-29
Anahtar Kelimeler: Rectal neoplasms, Fluorodeoxyglucose F-18, Positron emission tomography computed tomography, Diffusion magnetic resonance imaging, FDG-PET/CT, PATHOLOGICAL RESPONSE, EARLY PREDICTION, RADIOTHERAPY, THERAPY, CHEMORADIOTHERAPY, MANAGEMENT
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objective: Our aim is to evaluate if different metabolic parameters obtained by F-18-FDG PET/CT and diffusion weighted magnetic resonance imaging (DW-MRI) can aid in neoadjuvant radiochemotherapy (RCT) response assessment in locally advanced rectal cancer (LARC) patients.